Researchers are excited about the medication , a novel dual agonist showing promising data in initial trials for weight reduction . It acts by targeting both systems: GLP-1 and GIP, that , when https://kallumywme285934.blogkoo.com/a-new-possibility-for-body-reduction-60390874